Physician profile
Ayan Nasir
NPI 1124656459
$861.92
in general payments reported to CMS, 2019-2025
14 companies · $670 in 2025
The $670 reported for 2025 was more than what 78% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $42.19 · 2024: $150 · 2025: $670.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $862.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $861.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $279.28 | 2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals Lp | $104.08 | 2025 | Farxiga, Airsupra |
| Lilly USA, LLC | $95.80 | 2024-2025 | Mounjaro |
| Glaxosmithkline, LLC. | $79.57 | 2024-2025 | Benlysta, Nucala, Trelegy Ellipta |
| Sumitomo Pharma America, INC. | $65.31 | 2025 | Gemtesa |
| Amgen INC. | $58.38 | 2025 | Repatha, Otezla |
| Janssen Biotech, INC. | $42.18 | 2024 | Stelara, Simponi Aria |
| Teva Pharmaceuticals USA, INC. | $23.51 | 2024 | Simlandi |
| Otsuka America Pharmaceutical, INC. | $21.90 | 2023 | Rexulti |
| Pfizer INC. | $20.29 | 2023 | |
| Exact Sciences Corporation | $20.28 | 2025 | Cologuard Collection Kit |
| Abbvie INC. | $19.19 | 2025 | |
| Abbott Laboratories | $16.67 | 2025 | Freestyle Libre 3 |
| Phathom Pharmaceuticals, INC. | $15.48 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ayan Nasir listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.